ThoroughCare | $5,000,000 | (Nov 20, 2024)
OneChronos | $32,000,000 | (Nov 20, 2024)
EarthOptics | $24,000,000 | (Nov 20, 2024)
Route 92 Medical
United States
- San Mateo, California
- 20/11/2023
- Series F
- $31,000,000
About Route 92 Medical, Inc.
Route 92 Medical is on a mission to improve outcomes for patients undergoing minimally invasive brain procedures. At the core is a reconsidered procedural approach, cutting-edge engineering, and innovative product design. Our portfolio takes aim at the biggest challenges in neurointervention to deliver meaningful solutions to treat challenging diseases such as stroke. Founded by physicians, the company is focused upon developing thoughtful next generation products in collaboration with the world’s leading clinicians with the goal of improving procedural and patient outcomes.
The Monopoint operating platform received U.S. FDA 510(k) clearance in 2020. The company is currently enrolling the SUMMIT MAX randomized controlled trial under an FDA-approved Investigational Device Exemption.
- Industry Medical Equipment Manufacturing
- Website https://www.route92medical.com/
- LinkedIn https://www.linkedin.com/company/route-92-medical/about/
Related People
Tony ChouFounder
United States -
Boca Raton, Florida
Investor and advisor to developing health care companies that address major clinical needs.
Citizen Health | $14,500,000 | (Nov 20, 2024)
Kong Inc. | $175,000,000 | (Nov 20, 2024)
RIIG | $3,000,000 | (Nov 20, 2024)
Tokamak Energy | $12,000,000 | (Nov 20, 2024)
Taito.ai | $2,700,000 | (Nov 20, 2024)
OSYTE [O-Sight] | $4,000,000 | (Nov 20, 2024)
Levanta | $20,000,000 | (Nov 20, 2024)
Jimini Health | $8,000,000 | (Nov 20, 2024)
Kalder | $10,500,000 | (Nov 20, 2024)
Lightsynq | $18,000,000 | (Nov 20, 2024)